Barrington Research Reiterates “Outperform” Rating for Healthways Inc. (HWAY)
Healthways Inc. (NASDAQ:HWAY)‘s stock had its “outperform” rating reissued by stock analysts at Barrington Research in a note issued to investors on Thursday. They currently have a $30.00 target price on the stock, up from their prior target price of $29.00. Barrington Research’s price target points to a potential upside of 21.21% from the company’s current price.
Other research analysts have also issued reports about the stock. Zacks Investment Research raised shares of Healthways from a “hold” rating to a “buy” rating and set a $20.00 price objective on the stock in a research note on Monday, August 8th. Barclays PLC raised shares of Healthways from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $12.00 to $27.00 in a research report on Monday, August 22nd. Jefferies Group raised their price target on shares of Healthways from $13.00 to $18.50 and gave the company a “hold” rating in a research report on Thursday, August 4th. FBR & Co raised their price target on shares of Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, August 10th. Finally, Oppenheimer Holdings Inc. raised shares of Healthways to an “outperform” rating and set a $27.00 price target on the stock in a research report on Sunday, August 14th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Healthways currently has a consensus rating of “Buy” and an average target price of $26.50.
Shares of Healthways (NASDAQ:HWAY) opened at 24.75 on Thursday. The firm has a 50-day moving average of $25.34 and a 200-day moving average of $16.49. Healthways has a 12-month low of $9.18 and a 12-month high of $27.30. The company’s market cap is $909.27 million.
Healthways (NASDAQ:HWAY) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.53. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The firm had revenue of $125 million for the quarter, compared to analyst estimates of $186.88 million. During the same period last year, the firm earned $0.11 earnings per share. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. Analysts predict that Healthways will post $2.11 EPS for the current year.
In related news, Director Mary Jane England sold 3,816 shares of the firm’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $24.78, for a total transaction of $94,560.48. Following the completion of the sale, the director now owns 39,068 shares in the company, valued at $968,105.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 14.01% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the company. Prudential Financial Inc. increased its stake in Healthways by 3.6% in the first quarter. Prudential Financial Inc. now owns 73,984 shares of the company’s stock worth $746,000 after buying an additional 2,600 shares during the period. BlackRock Fund Advisors increased its position in Healthways by 1.7% in the first quarter. BlackRock Fund Advisors now owns 2,251,011 shares of the company’s stock valued at $22,713,000 after buying an additional 37,357 shares during the last quarter. Royce & Associates LP increased its position in Healthways by 13.4% in the first quarter. Royce & Associates LP now owns 903,204 shares of the company’s stock valued at $9,113,000 after buying an additional 106,500 shares during the last quarter. Bogle Investment Management L P DE acquired a new position in Healthways during the first quarter valued at $831,000. Finally, Jacobs Levy Equity Management Inc. acquired a new position in Healthways during the first quarter valued at $416,000. Institutional investors and hedge funds own 92.52% of the company’s stock.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.